Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic use of specific ligand in MSRV associated diseases

Therapeutic use of specific ligand in MSRV associated diseases

US Patent 9815888 · Granted Nov 14, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelop2021
Antiretroviral drug targeting human endogenous retrovirus2021
Antiretroviral drug targeting human endogenous retrovirus2021
Compounds for treating the remyelination blockade in diseases associated with th2020
Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by ne2020
Therapeutic use of specific ligand in MSRV associated diseases2018
Therapeutic use of specific ligand in MSRV associated diseases2018
Therapeutic use of specific ligand in MSRV associated diseases2018
Therapeutic use of specific ligand in MSRV associated diseases2018
Compounds for treating the remyelination blockade in diseases associated with th2017
Therapeutic use of specific ligand in MSRV associated diseases2017
Therapeutic use of specific ligand in MSRV associated diseases2017